Optimizing proteolytic digestion conditions for the analysis of serum albumin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a potential human carcinogen formed in cooked meat

被引:21
|
作者
Peng, Lijuan [1 ,2 ]
Turesky, Robert J. [2 ,3 ,4 ]
机构
[1] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan 430023, Peoples R China
[2] New York State Dept Hlth, Wadsworth Ctr, Div Environm Hlth Sci, Albany, NY 12201 USA
[3] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
关键词
Biomarkers; Protein adducts; Food carcinogens; MASS-SPECTROMETRIC CHARACTERIZATION; HETEROCYCLIC AROMATIC-AMINES; FOOD-BORNE CARCINOGEN; HEMOGLOBIN ADDUCTS; IN-VIVO; MOLECULAR DOSIMETRY; CYSTEINE ADDUCT; IDENTIFICATION; 4-AMINOBIPHENYL; QUANTIFICATION;
D O I
10.1016/j.jprot.2014.03.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Heterocyclic aromatic amines (HAAs) are carcinogens formed during the cooking of meats or arise in tobacco smoke. The genotoxic N-oxidized metabolites of HAAs bind to Cys residues of proteins to form arylsulfinamide adducts. However, these adducts are unstable and undergo hydrolysis during enzymatic digestion, and thus have been precluded as biomarkers of exposure to HAAs. Arylsulfinamide adducts of HAAs can undergo oxidation to form stable arylsulfonamide linkages, which are chemically stable and amenable for analysis. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a carcinogen present in cooked meat. We established a quantitative MS-based method to measure the sulfinamide adduct of PhIP formed at the cysteine(34) (Cys(34)) residue of human serum albumin (SA), following chemical oxidation of PhIP-moclified SA with m-chloroperoxybenzoic acid. Different enzyme systems (trypsin; chymotrypsin; trypsin/chymotrypsin; proteinase K; pronase E; and pronase E/leucine aminopeptidase/prolidase) were evaluated for their proficiency of digestion of SA modified with PhIP. The strongest signal was observed for the L(31)QQC*PFEDHVIC41 peptide, by ultraperformance liquid chromatography and ion trap MS. A limit of quantification value was 0.3 fmol of LQQC*PFEDHVK per mu g SA, or 2.5 adducts per 10(5) SA molecules, when assaying 0.75 mu g of SA. Biological significance This article describes a mass spectrometric based method to characterize and measure human serum albumin (SA) adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-11pyridine (PhIP), a carcinogenic heterocyclic aromatic amine formed in cooked meats and tobacco smoke. PhIP undergoes metabolic activation to form reactive N-oxidized intermediates that bind to DNA and proteins. N-oxidized PhIP metabolites bind to the Cys' residue of SA to form a sulfinamide linkage. However, the linkage undergoes hydrolysis during proteolysis, precluding the employment of this adduct as a biomarker in human studies. We have shown that the sulfinamide linkage undergoes oxidation to form the [cysteine-S-yl-PhIP]-S-dioxide, a sulfonamide linked adduct which is stable toward proteolysis. The specificity and efficiency of several different proteases toward the digestion of the SA-Cysm-PhIP adduct were examined. The combination of trypsin and chymotrypsin produced the single-missed cleaved peptide LQQC*PFEDHVK in high yield. Moreover, denaturation and chemical reduction of the internal Cys disulfide bonds of SA were not required for the recovery of LQQC*PFEDHVIC The novel chemistry and proteomic approaches developed in this study may be applied to monitor biologically reactive N-oxidized intermediates of arylamines through their adduction products formed at nucleophilic Cys residues of proteins. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:267 / 278
页数:12
相关论文
共 50 条
  • [31] Cancer chemoprevention from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Dashwood, RH
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 405 (01) : 109 - 110
  • [32] DETECTION OF A CARCINOGEN, 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP), IN CIGARETTE-SMOKE CONDENSATE
    MANABE, S
    TOHYAMA, K
    WADA, O
    ARAMAKI, T
    CARCINOGENESIS, 1991, 12 (10) : 1945 - 1947
  • [33] Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes
    Langouët, S
    Paehler, A
    Welti, DH
    Kerriguy, N
    Guillouzo, A
    Turesky, RJ
    CARCINOGENESIS, 2002, 23 (01) : 115 - 122
  • [34] Formation of the food associated carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in model systems
    Murkovic, M
    Weber, HJ
    Geiszler, S
    Fröhlich, K
    Pfannhauser, W
    FOOD CHEMISTRY, 1999, 65 (02) : 233 - 237
  • [35] Isolation and characterization of human intestinal bacteria capable of transforming the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Vanhaecke, Lynn
    Vercruysse, Filip
    Boon, Nico
    Verstraete, Willy
    Cleenwerck, Ilse
    De Wachter, Marjan
    De Vos, Paul
    van de Wiele, Tom
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2008, 74 (05) : 1469 - 1477
  • [36] Biomonitoring of urinary metabolites of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) following human consumption of cooked chicken
    Frandsen, H.
    FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (09) : 3200 - 3205
  • [37] IN-VITRO FORMATION AND DEGRADATION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) PROTEIN ADDUCTS
    REISTAD, R
    FRANDSEN, H
    GRIVAS, S
    ALEXANDER, J
    CARCINOGENESIS, 1994, 15 (11) : 2547 - 2552
  • [38] THE METABOLIC DISPOSITION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE IN THE INDUCED MOUSE
    TURTELTAUB, KW
    KNIZE, MG
    HEALY, SK
    TUCKER, JD
    FELTON, JS
    FOOD AND CHEMICAL TOXICOLOGY, 1989, 27 (10) : 667 - 673
  • [39] Active secretion of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) in the colon
    von Keutz, A.
    Schroeder, B.
    Breves, G.
    Steinberg, P.
    Nicken, P.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 63 - 63
  • [40] Comparison of crystal structure and theory for 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Parkin, S
    Marsch, GA
    Hope, H
    Whitney, E
    Winter, NW
    Colvin, ME
    Felton, JS
    Turteltaub, KW
    CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (03) : 574 - 579